Jeffrey Spaeder chief medical & scientific officer at Quintiles
This article was originally published in Scrip
Executive Summary
CRO Quintiles has appointed Dr Jeffrey Spaeder chief medical and scientific officer, succeeding Dr Oren Cohen who will now lead Quintiles' Phase I clinical research business. Dr Spaeder was most recently executive director of global medical affairs for Takeda Pharmaceuticals, where he worked on the strategy for the cardio-metabolic and diabetes franchises.